Thursday, 15 November 2018

MIT scientists design GPS system to track tumours

21 August 2018 | News

The team expects that such implants can be used to track tumours by monitoring even slight movements.

Image credit- health-innovations.org

Image credit- health-innovations.org

A team of scientists at the Massachusetts Institute of Technology (MIT) has developed an in-body GPS system, called ReMix, which can identify the location of ingestible implants inside the body via low-power wireless signals.

The team expects that such implants can be used to track tumours by monitoring even slight movements. In the future, the implants may also help in dispensing drugs to a specific area in the body.

ReMix is being developed by MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) in alliance with Massachusetts General Hospital (MGH).

The in-body GPS system is based on a wireless technology that MIT previously developed to detect heart rate, breathing and movement.

Further studies are required to improve the system’s accuracy and address any associated challenges.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Will the health insurance sector receive benefits from Ayushman Bharat?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls